# Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men

Study · id `cardio:ct-nct05806723` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05806723](<https://clinicaltrials.gov/study/NCT05806723>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05806723

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT05806723. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2022-07-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT05806723, source copy `cardio:ctgov-nct05806723-2023-04-10`, retrieved 2026-10-26)
- Started: 2021-03-01 (actual) (ClinicalTrials.gov record NCT05806723, source copy `cardio:ctgov-nct05806723-2023-04-10`, retrieved 2026-10-26)
- Primary completion: 2022-07-30 (actual) (ClinicalTrials.gov record NCT05806723, source copy `cardio:ctgov-nct05806723-2023-04-10`, retrieved 2026-10-26)
- Completion: 2022-09-15 (actual) (ClinicalTrials.gov record NCT05806723, source copy `cardio:ctgov-nct05806723-2023-04-10`, retrieved 2026-10-26)
- Countries: Tunisia (ClinicalTrials.gov record NCT05806723, source copy `cardio:ctgov-nct05806723-2023-04-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05806723-2023-04-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
- Condition: Diabetes Mellitus, Type 2
- Condition: Dyslipidemia Associated With Type II Diabetes Mellitus
- Condition: Statin Adverse Reaction
- Condition: Hypogonadism, Male
- Condition: Adrenal Insufficiency
- Condition: Vitamin D Deficiency
- Intervention (Drug): Atorvastatin 40 Mg Oral Tablet
- Lead sponsor: Hopital La Rabta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Provenance

Content hash: b2bcd3ab94e574156c7f56eeaaa971c058a9207dc92b8cdbb78fbe54e87525e8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
